HeartBeam (BEAT) Cash & Equivalents (2021 - 2026)

HeartBeam (BEAT) has reported Cash & Equivalents for 6 consecutive years, with $8.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 167.87% year-over-year to $8.7 million in Q2 2026; TTM through Jun 2026 was $8.7 million, a 167.87% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 84.27% from the prior year.
• Cash & Equivalents was $8.7 million for Q2 2026 at HeartBeam, up from $2.0 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $19.2 million in Q3 2023 and troughed at $990000.0 in Q1 2023.
• A 5-year average of $7.5 million and a median of $5.8 million in 2024 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 1176.57% in 2024, down 85.32% in 2024.
• Over 5 years, Cash & Equivalents stood at $3.6 million in 2022, then soared by 350.45% to $16.2 million in 2023, then sank by 85.32% to $2.4 million in 2024, then jumped by 84.27% to $4.4 million in 2025, then jumped by 99.13% to $8.7 million in 2026.
• The last three Cash & Equivalents figures came in at $8.7 million (Q2 2026), $2.0 million (Q1 2026), and $4.4 million (Q4 2025), per Business Quant data.